<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">research-focus</journal-id>
      <journal-title-group>
        <journal-title>Research Focus International Scientific Journal</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Research Focus</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub" publication-format="electronic">2181-3833</issn>
      <publisher>
        <publisher-name>Ilm-fan va innovatsiyalar akademiyasi</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.66073/researchfocus.v3i1.767</article-id>
      <article-id pub-id-type="other" assigning-authority="relibrary.uz">REL-A-012381</article-id>
      <article-categories>
        <subj-group subj-group-type="oak">
          <subject>14.00.00</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">OPTIMIZATION OF TREATMENT OF ATYPICAL PNEUMONIA DUE TO HYPOXIC-ISCHEMIC ENCEPHALOPATHY IN NEWBORNS</article-title>
        <trans-title-group xml:lang="ru">
          <trans-title>ОПТИМИЗАЦИЯ ЛЕЧЕНИЯ АТИПИЧНЫХ ПНЕВМОНИЙ НА ФОНЕ ГИПОКСИКО-ИШЕМИЧЕСКОЙ ЭНЦЕФАЛОПАТИИ У НОВОРОЖДЕННЫХ</trans-title>
        </trans-title-group>
        <trans-title-group xml:lang="uz">
          <trans-title>YANGI TUG‘ILGAN CHAQALOQLARDA GIPOKSIK-ISHEMIK ENSEFALOPATIYA FONIDA ATIPIK PNEVMONIYALARNI DAVOLASHNI OPTIMALLASHTIRISH</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group content-type="author">
        <contrib contrib-type="author">
          <string-name>Ibragimova Marina Fedorovna</string-name>
          <aff>PhD, Acting Associate Professor, Department № 1 of Pediatrics and Neonatology Samarkand State Medical University Samarkand, Uzbekistan</aff>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Esanova Munira Ravshanovna</string-name>
          <aff>2 year Master‘s student at Department № 1 of Pediatrics and Neonatology Samarkand State Medical University Samarkand, Uzbekistan</aff>
        </contrib>
      </contrib-group>
      <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2024-02-05">
        <day>05</day>
        <month>02</month>
        <year>2024</year>
      </pub-date>
      <pub-date date-type="collection">
        <year>2024</year>
      </pub-date>
      <volume>3</volume>
      <issue>1</issue>
      <fpage>220</fpage>
      <lpage>223</lpage>
      <permissions>
        <license xlink:href="https://creativecommons.org/licenses/by/4.0">
          <ali:license_ref>https://creativecommons.org/licenses/by/4.0</ali:license_ref>
          <license-p>This work is licensed under a Creative Commons Attribution 4.0 International License.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://relibrary.uz/REL-A-012381/"/>
      <abstract xml:lang="en">
        <p>Acute respiratory pathology occupies a leading place in the structure of morbidity in children. The leading place among them belongs to pneumonia, which is characterized by a high prevalence in the early age group, severity of the course, and the possibility of transition to severe forms. The purpose of the study is to develop new systems for complex therapy and rehabilitation of newborns with atypical pneumonia against the background of hypoxic-ischemic encephalopathy. Materials and methods of research: Group I – 40 children who received traditional treatment, of which 28 had a moderate-severe form and 12 had a severe form. Group II – 45 children who received, in addition to traditional treatment, cytochrome C, immunomodulin and of these, 32 are moderately severe and 13 are severe.</p>
      </abstract>
      <trans-abstract xml:lang="ru">
        <p>Острая респираторная патология занимает ведущее место в структуре заболеваемости у детей. Ведущее место среди них принадлежит пневмонии, которая характеризуется высокой распространенностью в группе раннего возраста, тяжестью течения и возможностью перехода в тяжелые формы. Цель исследования — разработать новые системы комплексной терапии и реабилитации новорожденных с атипичной пневмонией на фоне гипоксико-ишемической энцефалопатии. Материалы и методы исследования: I группа — 40 детей, получавших традиционное лечение, из них 28 со среднетяжелой формой и 12 с тяжелой формой. II группа — 45 детей, получавших дополнительно к традиционному лечению цитохром С, иммуномодулин, из них 32 среднетяжелых и 13 тяжелых.</p>
      </trans-abstract>
      <trans-abstract xml:lang="uz">
        <p>O‘tkir respirator patologiya bolalar kasallanishi tarkibida yetakchi o‘rinni egallaydi. Ular orasida yetakchi o‘rin pnevmoniyaga tegishli bo‘lib, u erta yoshdagi guruhda keng tarqalganligi, kechishining og‘irligi va og‘ir shakllarga o‘tish ehtimoli bilan tavsiflanadi. Tadqiqot maqsadi — gipoksik-ishemik ensefalopatiya fonida atipik pnevmoniya bilan og‘rigan yangi tug‘ilgan chaqaloqlarni kompleks davolash va reabilitatsiya qilishning yangi tizimlarini ishlab chiqish. Tadqiqot materiallari va usullari: I guruh — an‘anaviy davolash olgan 40 nafar bola, ulardan 28 tasida o‘rtacha og‘ir shakl va 12 tasida og‘ir shakl kuzatilgan. II guruh — an‘anaviy davolashga qo‘shimcha ravishda sitoxrom C, immunomodulin olgan 45 nafar bola, ulardan 32 tasi o‘rtacha og‘ir va 13 tasi og‘ir.</p>
      </trans-abstract>
      <kwd-group xml:lang="en">
        <kwd>atypical pneumonia</kwd>
        <kwd>newborns</kwd>
        <kwd>hypoxic-ischemic encephalopathy</kwd>
        <kwd>treatment</kwd>
      </kwd-group>
      <kwd-group xml:lang="ru">
        <kwd>атипичная пневмония</kwd>
        <kwd>новорожденные</kwd>
        <kwd>гипоксически-ишемическая энцефалопатия</kwd>
        <kwd>лечение</kwd>
      </kwd-group>
      <kwd-group xml:lang="uz">
        <kwd>atipik pnevmoniya</kwd>
        <kwd>yangi tug‘ilgan chaqaloqlar</kwd>
        <kwd>gipoksik-ishemik ensefalopatiya</kwd>
        <kwd>davolash</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <back>
    <ref-list>
      <ref id="r1">
        <label>1</label>
        <mixed-citation>Pravdukhina, G.P. Morphofunctional basis of the formation of encephalopathy in perinatal hypoxic-ischemic damage to the central nervous system / G.P. Pravdukhina, V.V. Semchenko // Med. science and education Ural. - 2012. -T. 13, No. 4. -S. 68-72.</mixed-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <mixed-citation>Sergeeva V.A., Aleksandrovich Yu.S., Petrenkova N.S. Predictors</mixed-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <mixed-citation>hypoxic-ischemic encephalopathy in newborns children. Bulletin of anesthesiology and resuscitation. 2017;14(4):16-22. <pub-id pub-id-type="doi">10.21292/2078-5658-2017-14-4-16-22</pub-id></mixed-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <mixed-citation>Fedorovna, I. M. (2022). The influence of risk factors on the development of atypical pneumonia in young children. Asian journal of pharmaceutical and biological research, 11(2).</mixed-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <mixed-citation>Ибрагимова, М. Ф. (2022). Применение препарата пектолван ц при лечении атипичной пневмонии у детей. Биология, 3, 136.</mixed-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <mixed-citation>Ибрагимова, М. Ф., &amp; Атаева, М. С. (2022). BOLALARDA ATIPIK PNEVMONIYANI DIAGNOSTIKA VA DAVOLASH USULLARINI TAKOMILLASHTIRISH. Журнал кардиореспираторных исследований, 3(2).</mixed-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <mixed-citation>Shavazi Н., &amp; Ibragimova М. (2023). USE OF POLYOXIDONIUM IN THE TREATMENT OF OBSTRUCTIVE BRONCHITIS IN CHILDREN. International Journal of Scientific Pediatrics, (1), 26–28. https://doi.org/<pub-id pub-id-type="doi">10.56121/2181-2926-2023-1-26-28</pub-id>.</mixed-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <mixed-citation>Fedorovna, I. M., &amp; Mamedovich, S. N. (2022). Improving Treatment in Children with Community-Acquired Pneumonia with Atypical Etiology. Telematique, 4644-4648.</mixed-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <mixed-citation>Ibragimova, M. F. (2022). DIAGNOSTIC CRITERIA FOR PNEUMONIA OF ATYPICAL ETIOLOGY IN CHILDREN. British medical journal, 2(5).</mixed-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <mixed-citation>Fedorovna, I. M., &amp; Shodiyorovna, G. D. (2023). IMPROVED DIAGNOSIS AND TREATMENT OF ATYPICAL PNEUMONIA IN CHILDREN. Thematics Journal of Applied Sciences, 7(1).</mixed-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <mixed-citation>Shavazi, N., Ibragimova, M., &amp; Munira, E. (2023). СОСТОЯНИЕ КЛЕТОЧНОГО ИММУНИТЕТА У БОЛЬНЫХ С ОБСТРУКТИВНЫМ БРОНХИТОМ. International Journal of Scientific Pediatrics, 2(9), 330-332. <pub-id pub-id-type="doi">10.56121/2181-2926-2023-2-9-330-332</pub-id></mixed-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <mixed-citation>Shavazi, N. M., Tursunkulova, D. A., Turaeva, N. O., &amp; Ibragimova, M. F. (2023). INFLUENCE OF NEGATIVE PREMORBID AND ECOLOPATHOLOGICAL FACTORS ON THE COURSE OF OBSTRUCTIVE BRONCHITIS IN CHILDREN AGAINST THE BACKGROUND OF HYPOXIC-ISCHEMIC ENCEPHALOPATHY. British Medical Journal, 3(2).</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
